Skip to content
About NovaMed

About NovaMed

A Nigerian pharmaceutical manufacturer rooted in disciplined quality systems, trusted partnerships, and a commitment to health access across Africa.

NovaMed

Our Story

Founded in 1981, NovaMed Pharmaceuticals Ltd. began with a simple mandate: manufacture essential medicines with uncompromising quality, close to the communities that need them most.

Over the decades, we have strengthened our quality management systems, expanded our portfolio across priority therapeutic areas, and built resilient distribution across multiple African markets.

Today, NovaMed continues to invest in people, science, and manufacturing excellence — guided by a culture of trust, compliance, and patient-first decisions.

NovaMed

Milestones

A Nigerian pharmaceutical manufacturer rooted in disciplined quality systems, trusted partnerships, and a commitment to health access across Africa.

1981

Founded

NovaMed begins as a local manufacturer focused on essential medicines.

1995

First export

First regional exports with strengthened quality systems and distribution.

2003

ISO Certified

ISO-aligned quality management systems to support consistent output.

2010

WHO Prequalification

Quality alignment to international expectations and dossier discipline.

2018

West Africa expansion

Broader market coverage supported by export-ready packaging and logistics.

2024

New R&D Centre

R&D centre commissioned to accelerate local formulation and tech transfer.

NovaMed

Mission, Vision & Core Values

Mission

Our mission

To manufacture quality-assured medicines that improve everyday health outcomes and strengthen healthcare resilience across Africa.

Vision

Our vision

To be Africa’s most trusted pharmaceutical manufacturing partner — defined by science, compliance, and measurable patient impact.

Values

Core values

  • Science-led decisions

    We anchor our work in evidence, rigorous quality, and continuous learning.

  • Trust by compliance

    We earn confidence through disciplined systems, documentation, and transparency.

  • Access and impact

    We design supply reliability and product availability for real-world needs.

NovaMed

Leadership Team

Experienced leaders across science, operations, and compliance.

Dr. Teniola Adeyemi, Chief Executive Officer at NovaMed Pharmaceuticals Ltd.

Dr. Teniola Adeyemi

Chief Executive Officer

A pharmacist and healthcare leader focused on expanding access to quality-assured medicines across Africa through disciplined manufacturing and ethical partnerships.

Amaka Nwosu, Chief Operating Officer at NovaMed Pharmaceuticals Ltd.

Amaka Nwosu

Chief Operating Officer

Operations executive with a track record in supply resilience, plant performance, and workforce development across multi-site manufacturing.

Kola Okafor, Chief Medical Officer at NovaMed Pharmaceuticals Ltd.

Kola Okafor

Chief Medical Officer

Clinical strategy leader supporting responsible product use, pharmacovigilance, and medical education aligned with public health priorities.

Zainab Bello, Chief Financial Officer at NovaMed Pharmaceuticals Ltd.

Zainab Bello

Chief Financial Officer

Finance leader focused on transparent reporting, disciplined investment, and long-term value creation for stakeholders.

Dr. Ifeanyi Nnamdi, Director, Research & Development at NovaMed Pharmaceuticals Ltd.

Dr. Ifeanyi Nnamdi

Director, Research & Development

Formulation scientist building local innovation capacity, stability readiness for African climates, and technology transfer partnerships.

Chidinma Eze, Director, Manufacturing at NovaMed Pharmaceuticals Ltd.

Chidinma Eze

Director, Manufacturing

Manufacturing excellence leader with deep experience in oral solids and continuous improvement programmes across regulated environments.

Adewale Hassan, Director, Regulatory & Compliance at NovaMed Pharmaceuticals Ltd.

Adewale Hassan

Director, Regulatory & Compliance

Regulatory specialist ensuring robust licensing, inspection readiness, and lifecycle stewardship aligned with NAFDAC and international expectations.

Uche Nwankwo, Director, Sales & Market Access at NovaMed Pharmaceuticals Ltd.

Uche Nwankwo

Director, Sales & Market Access

Commercial leader building ethical, data-informed go-to-market strategies that support availability and appropriate use.

NovaMed

Board of Directors

Engr. Amina Yusuf

Board Chair

Corporate governance leader with experience in industrial manufacturing, risk oversight, and strategic growth.

Prof. Chukwuemeka Obi

Independent Non-Executive Director

Academic and public health adviser with expertise in medicine policy, quality systems, and patient safety.

Mrs. Laila Sanusi

Independent Non-Executive Director

Finance and audit specialist with strong oversight in reporting integrity and compliance controls.

Dr. Teniola Adeyemi

Executive Director

Chief Executive Officer providing operational leadership and long-term strategy execution.

Our presence across Africa

Nigeria • Ghana • Kenya • South Africa • Cameroon • Senegal

6 markets

NovaMed

Awards & Recognitions

ISO-aligned quality management milestones

Manufacturing excellence recognition (regional)

Workforce development and training systems commendations